Company profile: Flowonix Medical
1.1 - Company Overview
Company description
- Provider of medical device solutions for patients with chronic disorders, featuring the Prometra Programmable Infusion Pump System, an implantable intrathecal drug delivery system indicated for use with specific medications to treat chronic pain and spasticity in adults and adolescents.
Products and services
- Prometra Programmable Infusion Pump System: Implantable intrathecal drug delivery system indicated for specific medications to treat chronic pain and spasticity in adults and adolescents
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Flowonix Medical
Liquidia
HQ: United States
Website
- Description: Provider of biopharmaceutical therapies for pulmonary hypertension. Portfolio includes investigational treprostinil products YUTREPIA (inhaled dry powder) and L606 (sustained-release liposomal via next-generation nebulizer) for PAH and PH-ILD; a fully substitutable generic treprostinil injection for PAH promoted with Sandoz; and PRINT Technology to create precise drug particles for enhanced lung delivery.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Liquidia company profile →
PharmaJet
HQ: United States
Website
- Description: Provider of needle-free jet injection systems for fixed-dose intradermal, intramuscular, and subcutaneous vaccine delivery. Offerings include Tropis ID (0.1 ml intradermal), Stratis IM/SC (0.5 ml IM/SC with charging station), and platforms for nucleic acid, COVID-19 (e.g., ZyCoV-D), polio, and influenza (e.g., Afluria) vaccine delivery, enhancing cellular dispersion and immunogenicity and providing an alternative to needles.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full PharmaJet company profile →
ActivaTek
HQ: United States
Website
- Description: Provider of drug delivery and other medical devices, including iontophoretic products for the rehabilitation market. Manufacturer of ActivaDose dose controllers; ActivaDose II houses a 9-volt battery and features precise dosing, visual and audible displays, and dual channels.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ActivaTek company profile →
Lyra Therapeutics
HQ: United States
Website
- Description: Provider of clinical-stage therapeutics for ear, nose, and throat diseases, including LYR-210 and LYR-220, bioabsorbable nasal mesh implants that deliver up to six months of continuous mometasone furoate for chronic rhinosinusitis, and the XTreo platform, a proprietary technology for direct, consistent, sustained drug delivery to affected tissues with a single administration.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Lyra Therapeutics company profile →
Emisphere Technologies
HQ: United States
Website
- Description: Provider of proprietary Eligen Technology to develop new oral formulations of therapeutic agents, enhancing absorption of drugs typically administered via injection. A pharmaceutical company with multiple product candidates in clinical development and several in pre-clinical research.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Emisphere Technologies company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Flowonix Medical
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Flowonix Medical
2.2 - Growth funds investing in similar companies to Flowonix Medical
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Flowonix Medical
4.2 - Public trading comparable groups for Flowonix Medical
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →